glucose, (beta-d)-isomer has been researched along with Cardiometabolic Syndrome in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (4.17) | 29.6817 |
| 2010's | 14 (58.33) | 24.3611 |
| 2020's | 9 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Kuo, WH; Lee, CT; Lee, WC; Leung, FF; Ng, HY; Tain, YL | 1 |
| Cheng, L; Fan, Y; Fu, Q; Lin, W; Liu, F; Wu, X; Zhang, X; Zhou, L | 1 |
| Miyagi, K; Miyazaki, R | 1 |
| Dai, X; Hao, H; Li, Y; Ou, T; Wang, D; Wang, R; Wang, W; Yong, H | 1 |
| Fuchigami, A; Higa, M; Hirose, T; Hiyoshi, T; Ichijo, T; Inoue, I; Iso, K; Kitazawa, T; Kumashiro, N; Okada, Y; Shigiyama, F; Yoshii, H | 1 |
| Auger, C; Benrahla, D; Bruckert, C; Farooq, MA; Gaertner, S; Lee, HH; Lessinger, JM; Mayoux, E; Morel, O; Ohlmann, P; Park, SH; Pollet, B; Qureshi, AW; Schini-Kerth, VB; Stephan, D | 1 |
| Bellalah, A; Bouhajeb, R; Chekir-Ghedira, L; Dhaouefi, Z; Khlifi, R; Lahmar, A; Sioud, F; Toumia, IB | 1 |
| Ferreira, JP; Fitchett, D; George, J; Inzucchi, SE; Lauer, S; Ofstad, AP; Verma, S; Wanner, C; Zinman, B; Zwiener, I | 1 |
| Chou, TW; Jhuo, SJ; Lai, WT; Lee, KT; Lin, YH; Liu, IH; Tasi, WC; Wu, BN | 1 |
| Güllich, A; Manfredini, V; Oliveira, P; Piccoli, J; Pilar, B; Ströher, D | 1 |
| Eckel, RH; Koh, KK; Lim, S | 1 |
| Bona, NP; Carvalho, FB; Chaves, VC; Gutierres, JM; Lencina, CL; Mendonça, LT; Oliveira, PS; Reginatto, FH; Soares, MSP; Spanevello, RM; Stefanello, FM; Vasconcellos, FA; Vieira, A; Vizzotto, M | 1 |
| Olgar, Y; Turan, B | 1 |
| Akkus, E; Degirmenci, S; Durak, A; Olgar, Y; Tuncay, E; Turan, B | 1 |
| Ahn, MH; Baek, SH; D'Souza, R; Hong, ST; Hwang, E; Jeon, JS; Jeon, Y; Kang, HJ; Kim, HJ; Kim, SY; Lee, DW; Lee, HS; Lee, SW; Moon, E; Ryu, HS; Seo, CS; Shin, WC | 1 |
| García, SD; Sanz, AD; Sanz, SD | 1 |
| Bhaswant, M; Brown, L; Fanning, K; Mathai, ML; Netzel, M; Panchal, SK | 1 |
| Adkins, YC; Bonnel, EL; Breksa, AP; Freytag, TL; Kelley, DS; Mackey, BE; Manners, GD; Storms, DH; Woodhouse, LR; Zunino, SJ | 1 |
| Chellan, N; Joubert, E; Malherbe, CJ; Miura, Y; Muller, CJF; Yagasaki, K | 1 |
| Hasegawa, Y; Kim-Mitsuyama, S; Koibuchi, N; Kusaka, H; Ogawa, H | 1 |
| González-Ortiz, M; Martínez-Abundis, E; Méndez-Del Villar, M; Ramírez-Rodríguez, AM | 1 |
| Adams, AA; Barker, VD; Elzinga, SE; McQuerry, K; Rohleder, B; Schanbacher, B | 1 |
| Eckhardt, M; Eickelmann, P; Grempler, R; Himmelsbach, F; Klein, T; Mark, M; Sauer, A; Thomas, L | 1 |
| Abudula, R; Colombo, M; Dyrskog, SE; Hermansen, K; Jeppesen, PB | 1 |
3 review(s) available for glucose, (beta-d)-isomer and Cardiometabolic Syndrome
| Article | Year |
|---|---|
Clinical implications of current cardiovascular outcome trials with sodium glucose cotransporter-2 (SGLT2) inhibitors.
Topics: Albuminuria; Atherosclerosis; Benzhydryl Compounds; Body Weight; Canagliflozin; Cardiovascular Diseases; Cardiovascular System; Glucagon; Glucagon-Like Peptides; Glucosides; Heart Failure; Hemodynamics; Humans; Hypoglycemic Agents; Ketones; Lipids; Liraglutide; Metabolic Syndrome; Metformin; Non-alcoholic Fatty Liver Disease; Osmosis; Risk Factors; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome | 2018 |
[Type 2 diabetes mellitus and obesity: should we treat the obesity or the diabetes?].
Topics: Bariatric Surgery; Benzhydryl Compounds; Causality; Comorbidity; Diabetes Mellitus, Type 2; Diet, Diabetic; Diet, Reducing; Disease Management; Evidence-Based Medicine; Exercise Therapy; Glucagon-Like Peptide 1; Glucosides; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Metabolic Syndrome; Obesity; Practice Guidelines as Topic; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Weight Loss | 2013 |
Potential of rooibos, its major C-glucosyl flavonoids, and Z-2-(β-D-glucopyranosyloxy)-3-phenylpropenoic acid in prevention of metabolic syndrome.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Aspalathus; Beverages; Diabetes Mellitus, Type 2; Dietary Supplements; Ethnopharmacology; Flavonoids; Glucosides; Humans; Isomerism; Medicine, African Traditional; Metabolic Syndrome; Obesity; Phenylpropionates; Plant Extracts; Plant Leaves; Plant Stems; South Africa; Teas, Herbal | 2018 |
5 trial(s) available for glucose, (beta-d)-isomer and Cardiometabolic Syndrome
| Article | Year |
|---|---|
Liraglutide Plus Dapagliflozin for High Uric Acid and Microalbuminuria in Diabetes Mellitus Complicated With Metabolic Syndrome.
Topics: Benzhydryl Compounds; Diabetes Mellitus; Diabetes Mellitus, Type 2; Glucosides; Glycolipids; Humans; Liraglutide; Metabolic Syndrome; Quality of Life; Stroke Volume; Uric Acid; Ventricular Function, Left | 2022 |
Efficacy of dapagliflozin versus sitagliptin on cardiometabolic risk factors in Japanese patients with type 2 diabetes: a prospective, randomized study (DIVERSITY-CVR).
Topics: Aged; Benzhydryl Compounds; Biomarkers; Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Glucosides; Glycated Hemoglobin; Humans; Japan; Male; Metabolic Syndrome; Middle Aged; Prospective Studies; Risk Assessment; Risk Factors; Sitagliptin Phosphate; Sodium-Glucose Transporter 2 Inhibitors; Time Factors; Treatment Outcome; Weight Loss | 2020 |
Metabolic syndrome in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a post hoc analyses of the EMPA-REG OUTCOME trial.
Topics: Aged; Atherosclerosis; Benzhydryl Compounds; Diabetes Mellitus, Type 2; Female; Glucosides; Heart Diseases; Humans; Kidney Diseases; Male; Metabolic Syndrome; Middle Aged; Risk Assessment; Risk Factors; Sodium-Glucose Transporter 2 Inhibitors; Time Factors; Treatment Outcome | 2020 |
Dietary supplementation with purified citrus limonin glucoside does not alter ex vivo functions of circulating T lymphocytes or monocytes in overweight/obese human adults.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Beverages; Biomarkers; Body Mass Index; Cell Proliferation; Cells, Cultured; Citrus; Cross-Over Studies; Dietary Supplements; Double-Blind Method; Female; Fruit; Glucosides; Hepatitis; Humans; Limonins; Male; Metabolic Syndrome; Middle Aged; Monocytes; Obesity; Overweight; T-Lymphocytes | 2016 |
Effect of dapagliflozin administration on metabolic syndrome, insulin sensitivity, and insulin secretion.
Topics: Adult; Benzhydryl Compounds; Blood Glucose; Double-Blind Method; Female; Glucosides; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Lipids; Male; Metabolic Syndrome; Middle Aged; Weight Loss | 2018 |
16 other study(ies) available for glucose, (beta-d)-isomer and Cardiometabolic Syndrome
| Article | Year |
|---|---|
Effect of Dapagliflozin and Magnesium Supplementation on Renal Magnesium Handling and Magnesium Homeostasis in Metabolic Syndrome.
Topics: Animals; Benzhydryl Compounds; Diet, Carbohydrate Loading; Dietary Supplements; Disease Models, Animal; Fructose; Glucosides; Homeostasis; Insulin Resistance; Kidney; Kidney Tubules; Magnesium; Magnesium Deficiency; Magnesium Sulfate; Metabolic Syndrome; Rats; Sodium-Glucose Transporter 2 Inhibitors; TRPM Cation Channels | 2021 |
Dapagliflozin, metformin, monotherapy or both in patients with metabolic syndrome.
Topics: Adult; Benzhydryl Compounds; Body Weight; C-Reactive Protein; Cholesterol, HDL; Diabetes Mellitus, Type 2; Female; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Inflammation; Insulin; Male; Metabolic Syndrome; Metformin; Middle Aged; Monocytes | 2021 |
Empagliflozin in kidney transplant recipients with chronic kidney disease G3a-4 and metabolic syndrome: Five Japanese cases.
Topics: Benzhydryl Compounds; Diabetes Mellitus, Type 2; Female; Glucosides; Humans; Japan; Kidney Transplantation; Male; Metabolic Syndrome; Renal Insufficiency, Chronic; Sodium-Glucose Transporter 2 Inhibitors | 2022 |
Empagliflozin improved systolic blood pressure, endothelial dysfunction and heart remodeling in the metabolic syndrome ZSF1 rat.
Topics: Animals; Benzhydryl Compounds; Biomarkers; Blood Glucose; Blood Pressure; Cellular Senescence; Disease Models, Animal; Endothelium, Vascular; Glucosides; Metabolic Syndrome; Obesity; Rats, Zucker; Sodium-Glucose Transporter 2 Inhibitors; Systole; Ventricular Function, Left; Ventricular Remodeling | 2020 |
Erica multiflora extract rich in quercetin-3-O-glucoside and kaempferol-3-O-glucoside alleviates high fat and fructose diet-induced fatty liver disease by modulating metabolic and inflammatory pathways in Wistar rats.
Topics: Animals; Diet, High-Fat; Dietary Fats; Ericales; Fatty Liver; Fructose; Glucosides; Inflammation; Insulin Resistance; Kaempferols; Liver; Male; Metabolic Syndrome; Methanol; Monosaccharides; Oxidative Stress; Plant Extracts; Quercetin; Rats; Rats, Wistar; Reactive Oxygen Species; Tandem Mass Spectrometry | 2020 |
Characteristics of Ventricular Electrophysiological Substrates in Metabolic Mice Treated with Empagliflozin.
Topics: Animals; Benzhydryl Compounds; Cardiovascular Diseases; Connexin 43; Connexins; Diet, High-Fat; Disease Models, Animal; Echocardiography; Electrocardiography; Gene Expression Regulation; Glucose; Glucosides; Glyburide; Humans; Metabolic Syndrome; Mice; Sodium-Glucose Transporter 2 | 2021 |
Protective Role of Flaxseed Oil and Flaxseed Lignan Secoisolariciresinol Diglucoside Against Oxidative Stress in Rats with Metabolic Syndrome.
Topics: Animals; Antioxidants; Body Weight; Butylene Glycols; Flax; Fructose; Glucose; Glucosides; Humans; Lignans; Linseed Oil; Lipids; Male; Metabolic Syndrome; Oxidative Stress; Protective Agents; Quality of Life; Rats | 2017 |
Southern Brazilian native fruit shows neurochemical, metabolic and behavioral benefits in an animal model of metabolic syndrome.
Topics: Animals; Anthocyanins; Antidepressive Agents; Antioxidants; Behavior, Animal; Brazil; Catalase; Corpus Striatum; Diet, Carbohydrate Loading; Disease Models, Animal; Glucose Intolerance; Glucosides; Hippocampus; Hypoglycemic Agents; Hypolipidemic Agents; Metabolic Syndrome; Neuroprotective Agents; Oxidative Stress; Plant Extracts; Psidium; Rats; Rats, Wistar; Tandem Mass Spectrometry; Weight Gain | 2018 |
A sodium-glucose cotransporter 2 (SGLT2) inhibitor dapagliflozin comparison with insulin shows important effects on Zn
Topics: Animals; Benzhydryl Compounds; Biological Transport; Endoplasmic Reticulum; Gene Expression Regulation; Glucosides; Insulin; Insulin Resistance; Male; Matrix Metalloproteinases; Metabolic Syndrome; Myocytes, Cardiac; Oxidative Stress; Proteolysis; Rats; Rats, Wistar; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Zinc | 2019 |
A SGLT2 inhibitor dapagliflozin suppresses prolonged ventricular-repolarization through augmentation of mitochondrial function in insulin-resistant metabolic syndrome rats.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Benzhydryl Compounds; Blood Glucose; Disease Models, Animal; Glucosides; Heart Rate; Heart Ventricles; Insulin; Insulin Resistance; Male; Membrane Potential, Mitochondrial; Metabolic Syndrome; Mitochondria, Heart; Myocytes, Cardiac; Potassium Channels, Voltage-Gated; Rats, Wistar; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Ventricular Function, Left; Voltage-Gated Sodium Channels | 2018 |
Creation of resveratrol-enriched rice for the treatment of metabolic syndrome and related diseases.
Topics: Acyltransferases; Adipose Tissue; Animals; Blood Glucose; Body Weight; Chromatography, High Pressure Liquid; Female; Food, Fortified; Glucosides; Glucosyltransferases; Humans; Lipids; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Oryza; Plant Leaves; Plants, Genetically Modified; Resveratrol; Seeds; Sirtuin 1; Stilbenes | 2013 |
Cyanidin 3-glucoside improves diet-induced metabolic syndrome in rats.
Topics: Animals; Anthocyanins; Cardiovascular System; Diet, High-Fat; Dietary Carbohydrates; Dietary Fats; Dietary Supplements; Fruit and Vegetable Juices; Glucosides; Hypertension; Liver; Male; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Prunus domestica; Rats; Rats, Wistar | 2015 |
Empagliflozin lessened cardiac injury and reduced visceral adipocyte hypertrophy in prediabetic rats with metabolic syndrome.
Topics: Adipocytes, White; Adiposity; Animals; Benzhydryl Compounds; Biomarkers; Cardiomegaly; Disease Models, Animal; Diuresis; Glucosides; Hemodynamics; Hypertrophy; Hypoglycemic Agents; Intra-Abdominal Fat; Male; Metabolic Syndrome; Oxidative Stress; Prediabetic State; Rats, Inbred SHR; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Time Factors; Water-Electrolyte Balance; Weight Gain | 2016 |
Metabolic and inflammatory responses to the common sweetener stevioside and a glycemic challenge in horses with equine metabolic syndrome.
Topics: Animals; Blood Glucose; Case-Control Studies; Diterpenes, Kaurane; Glucosides; Horse Diseases; Horses; Inflammation; Insulin; Metabolic Syndrome; Sweetening Agents | 2017 |
Long-term treatment with empagliflozin, a novel, potent and selective SGLT-2 inhibitor, improves glycaemic control and features of metabolic syndrome in diabetic rats.
Topics: Animals; Benzhydryl Compounds; Blood Glucose; Glucose Clamp Technique; Glucosides; Glycated Hemoglobin; Hypoglycemic Agents; Male; Metabolic Syndrome; Rats; Rats, Zucker; Sodium-Glucose Transporter 2 Inhibitors | 2012 |
Preventive effects of a soy-based diet supplemented with stevioside on the development of the metabolic syndrome and type 2 diabetes in Zucker diabetic fatty rats.
Topics: Animals; Blood Glucose; Blood Pressure; Cholesterol; Diabetes Mellitus, Type 2; Diterpenes, Kaurane; Fasting; Fatty Acids, Nonesterified; Glucosides; Male; Metabolic Syndrome; Rats; Rats, Zucker; Soy Foods; Sweetening Agents; Triglycerides | 2005 |